Related Experiment Video
Updated: Feb 4, 2026

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
Bactericidal activity of ceftobiprole combined with different antibiotics against selected Gram-positive isolates
F Campanile1, D Bongiorno1, G Mongelli1
1MMARLab, Department of Biomedical and Biotechnological Sciences, University of Catania, Italy.
Abstract:
This study investigated the in vitro susceptibility of ceftobiprole and its potential synergistic activity in combination with other antimicrobials against 46 selected Gram-positive pathogens displaying resistance or decrease susceptibility to several drugs. The gradient-cross method was used to assess synergism between ceftobiprole and daptomycin, levofloxacin, linezolid, rifampicin and piperacillin/tazobactam. Time-kill curves were performed for seven representative isolates. Ceftobiprole MICs ranged from 0.25-6 mg/L for staphylococci; 4-≥32 mg/L for Enterococcus faecalis, and 0.38-≥32 mg/L for E. faecium. Ceftobiprole plus daptomycin was synergistic against all isolates. Ceftobiprole plus linezolid was synergistic against 4 isolates belonging to different species. Ceftobiprole plus levofloxacin was synergistic only against enterococci. In conclusion, ceftobiprole exhibited a potent in vitro antibacterial activity and exhibited synergy with daptomycin against all Gram-positive isolates, despite their antibiotic resistance phenotypes. The use of ceftobiprole in combination may provide a promising alternative therapy for the treatment of resistant Gram-positive infections.
More Related Videos
Related Concept Videos
Antibiotic Selection
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Position-effect Variegation
Positive Regulator Molecules
What is Natural Selection?
Development of Antibiotic Resistance

